1. Home
  2. SLNO vs SBLK Comparison

SLNO vs SBLK Comparison

Compare SLNO & SBLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • SBLK
  • Stock Information
  • Founded
  • SLNO 1999
  • SBLK 2006
  • Country
  • SLNO United States
  • SBLK Greece
  • Employees
  • SLNO N/A
  • SBLK N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SBLK Marine Transportation
  • Sector
  • SLNO Health Care
  • SBLK Consumer Discretionary
  • Exchange
  • SLNO Nasdaq
  • SBLK Nasdaq
  • Market Cap
  • SLNO 2.3B
  • SBLK 1.9B
  • IPO Year
  • SLNO 2014
  • SBLK N/A
  • Fundamental
  • Price
  • SLNO $69.98
  • SBLK $13.79
  • Analyst Decision
  • SLNO Strong Buy
  • SBLK Strong Buy
  • Analyst Count
  • SLNO 8
  • SBLK 3
  • Target Price
  • SLNO $95.75
  • SBLK $22.67
  • AVG Volume (30 Days)
  • SLNO 2.6M
  • SBLK 1.9M
  • Earning Date
  • SLNO 05-08-2025
  • SBLK 05-21-2025
  • Dividend Yield
  • SLNO N/A
  • SBLK 15.79%
  • EPS Growth
  • SLNO N/A
  • SBLK 60.00
  • EPS
  • SLNO N/A
  • SBLK 2.80
  • Revenue
  • SLNO N/A
  • SBLK $1,265,458,000.00
  • Revenue This Year
  • SLNO N/A
  • SBLK N/A
  • Revenue Next Year
  • SLNO N/A
  • SBLK $18.23
  • P/E Ratio
  • SLNO N/A
  • SBLK $4.93
  • Revenue Growth
  • SLNO N/A
  • SBLK 33.31
  • 52 Week Low
  • SLNO $36.61
  • SBLK $12.06
  • 52 Week High
  • SLNO $74.00
  • SBLK $27.47
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 62.10
  • SBLK 42.36
  • Support Level
  • SLNO $57.01
  • SBLK $13.40
  • Resistance Level
  • SLNO $71.00
  • SBLK $14.49
  • Average True Range (ATR)
  • SLNO 5.29
  • SBLK 0.76
  • MACD
  • SLNO -0.08
  • SBLK -0.07
  • Stochastic Oscillator
  • SLNO 76.34
  • SBLK 46.13

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About SBLK Star Bulk Carriers Corp.

Star Bulk Carriers Corp provides seaborne transportation solutions in the dry bulk sector. The company owns and operates dry bulk carrier vessels, which are used to transport bulk, such as iron ore, coal, grains, bauxite, fertilizers, and steel products. It owns a fleet of vessels that consists of Newcastlemax, Capesize, Post Panamax, Kamsarmax, Panamax, Ultramax, and Supramax. It generates revenues through the voyages it carries out.

Share on Social Networks: